The safety of triptans in the treatment of patients with migraine
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference63 articles.
1. Prevalence of migraine in the United States;Stewart;JAMA,1992
2. Practice parameter;Silberstein;Neurology,2000
3. Imitrex Tablets,2000
4. Imitrex Injection,2000
5. Imitrex Nasal Spray,2000
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside;Nature Reviews Neurology;2023-07-12
2. Rimegepant 75 mg in Subjects With Hepatic Impairment: Results of a Phase 1, Open‐Label, Single‐Dose, Parallel‐Group Study;Clinical Pharmacology in Drug Development;2023-04-18
3. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial;Pain and Therapy;2022-06-04
4. A New Technique Employing Direct Tactile Pressure on the Common Carotid Artery to Relieve Acute Episode Attack of Migraine Headache: A Single-Arm Interventional Study;FRONT EMERG MED;2021
5. Optimal dosing of lasmiditan in the management of acute migraine attack: A systematic review and meta-analysis;Annals of Indian Academy of Neurology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3